|
|
Volumn 87, Issue 7, 2001, Pages 599-601
|
|
The current status of interferon-α treatment in advanced renal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
FLUOROURACIL;
INTERLEUKIN 2;
ISOTRETINOIN;
MEDROXYPROGESTERONE;
TAMOXIFEN;
THALIDOMIDE;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ANXIETY NEUROSIS;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONSTIPATION;
DEPRESSION;
DIARRHEA;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFICACY;
FATIGUE;
FEVER;
HUMAN;
INFLUENZA;
IRRITABILITY;
KIDNEY CANCER;
MACROPHAGE;
METASTASIS;
NAUSEA;
NEPHRECTOMY;
PAIN;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
SLEEP DISORDER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
FORECASTING;
HUMANS;
INTERFERON-ALPHA;
KIDNEY NEOPLASMS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
|
|
EID: 0035731479
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2001.02140.x Document Type: Review |
|
Times cited : (11)
|
|
References (20)
|
